Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial.

Han HS, Aldrich AL, Garg SK, Weinfurtner RJ, Nguyen JV, Mo Q, Whiting J, Childress J, Soliman H, Costa R, Armaghani A, Soyano A, Kiluk J, Hoover S, Lee MC, Khakpour N, Shenoi N, Jameel Z, Koski GK, Czerniecki BJ

Open source

DOI: 10.1001/jamaoncol.2024.5371
Published: 2025 Feb 1
Container: JAMA oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2024.5371,
  title = {Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial.},
  author = {Han HS and Aldrich AL and Garg SK and Weinfurtner RJ and Nguyen JV and Mo Q and Whiting J and Childress J and Soliman H and Costa R and Armaghani A and Soyano A and Kiluk J and Hoover S and Lee MC and Khakpour N and Shenoi N and Jameel Z and Koski GK and Czerniecki BJ},
  year = {2025},
  journal = {JAMA oncology},
  doi = {10.1001/jamaoncol.2024.5371},
  url = {https://doi.org/10.1001/jamaoncol.2024.5371}
}

RIS

TY  - JOUR
TI  - Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial.
AU  - Han HS
AU  - Aldrich AL
AU  - Garg SK
AU  - Weinfurtner RJ
AU  - Nguyen JV
AU  - Mo Q
AU  - Whiting J
AU  - Childress J
AU  - Soliman H
AU  - Costa R
AU  - Armaghani A
AU  - Soyano A
AU  - Kiluk J
AU  - Hoover S
AU  - Lee MC
AU  - Khakpour N
AU  - Shenoi N
AU  - Jameel Z
AU  - Koski GK
AU  - Czerniecki BJ
PY  - 2025
JO  - JAMA oncology
DO  - 10.1001/jamaoncol.2024.5371
UR  - https://doi.org/10.1001/jamaoncol.2024.5371
ER  -

APA

HS, H., AL, A., SK, G., RJ, W., JV, N., Q, M., J, W., J, C., H, S., R, C., A, A., A, S., J, K., S, H., MC, L., N, K., N, S., Z, J., GK, K., & BJ, C. (2025). Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial.. JAMA oncology. https://doi.org/10.1001/jamaoncol.2024.5371

Source records

pubmed · retrieved 2026-09-25T15:18:44.597Z